Alembic Pharmaceuticals dividend 2025

APLLTD

853.75

6.15 (-0.72%)
Last updated on 22 Dec, 2025 | 15:31 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Alembic Pharmaceuticals Dividend Details

Record Date

29-Jul-2025

Dividends Date

29-Jul-2025

Ex Date

29-Jul-2025

Dividend Type

Equity Share

Dividend Per Share

550.00

The Alembic Pharmaceuticals has declared a Equity Share dividend of 550 per share. Investors should note the record date of 29-Jul-2025, and the ex-dividend date 29-Jul-2025 to confirm eligibility for the payout. This move underscores the company’s ongoing efforts to enhance shareholder value through regular dividend distributions.

Alembic Pharmaceuticals Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
29-Jul-20255.50Equity Share29-Jul-2025

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
Prakash Pipes Ltd.0.118-Dec-202524-Dec-202524-Dec-2025

Alembic Pharmaceuticals Dividend FAQs

The latest dividend declared by Alembic Pharmaceuticals is of 5.5 per share for the financial year as announced on 29-Jul-2025.

Registered shareholders who own Alembic Pharmaceuticals’s shares on or before the record date of 29-Jul-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 29-Jul-2025.

You can expect to receive Alembic Pharmaceuticals’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 29-Jul-2025. The record date is when Alembic Pharmaceuticals identifies eligible shareholders for the dividend payment.

The annual dividend paid by Alembic Pharmaceuticals varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Alembic Pharmaceuticals's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.